Tiernan J. Mulrooney, Ph.D. - Publications

Affiliations: 
2012 Tumor Biology Georgetown University, Washington, DC 
Area:
Immunology, Molecular Biology, Oncology

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Boudreau JE, Mulrooney TJ, Le Luduec JB, Barker E, Hsu KC. KIR3DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV. Journal of Immunology (Baltimore, Md. : 1950). 196: 3398-410. PMID 26962229 DOI: 10.4049/Jimmunol.1502469  0.414
2015 Mulrooney TJ, Zhang AC, Goldgur Y, Boudreau JE, Hsu KC. KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding. Journal of Immunology (Baltimore, Md. : 1950). 195: 1242-50. PMID 26109640 DOI: 10.4049/Jimmunol.1500243  0.54
2013 Mulrooney TJ, Posch PE, Hurley CK. DAP12 impacts trafficking and surface stability of killer immunoglobulin-like receptors on natural killer cells Journal of Leukocyte Biology. 94: 301-313. PMID 23715743 DOI: 10.1189/Jlb.0213093  0.501
2009 VandenBussche CJ, Mulrooney TJ, Frazier WR, Dakshanamurthy S, Hurley CK. Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule Genes and Immunity. 10: 162-173. PMID 19005473 DOI: 10.1038/Gene.2008.91  0.519
2008 Mulrooney TJ, Hou L, Steiner NK, Chen M, Belle I, Ng J, Hurley CK. Promoter variants of KIR2DL5 add to diversity and may impact gene expression. Immunogenetics. 60: 287-94. PMID 18461314 DOI: 10.1007/S00251-008-0273-7  0.418
Show low-probability matches.